Pre-U.S. Travel COVID Testing Returns For Travelers From China, Macau And Hong Kong – General Immigration

To print this article, simply register or log in to

Due to the surge in the number of COVID cases in China and the number of new virus variant cases, the Centers for Disease Control and Prevention (CDC) has announced the reinstatement of COVID testing requirements for air passengers from the People’s Republic of China and Macau Special Administrative Region. Hong Kong.

Who does this affect?

  • Passengers over the age of 2 on flights to the United States from China, Macau and Hong Kong.
  • Passengers 2 years of age and older on flights to the United States from Incheon International Airport (Seoul, South Korea), Toronto Pearson International Airport (Toronto, Ontario, Canada) and Vancouver International Airport (Vancouver, British Columbia, Canada). Before the flight, he had been in China, Macau or Hong Kong within 10 days.
  • Travelers from China, Macau, or Hong Kong arriving in the United States from a third country (not direct from China, Macau, or Hong Kong).
  • Travelers from China, Macau, or Hong Kong staying only in the United States for transit or transit to another destination.
  • Finally, this requirement applies to these travelers regardless of nationality or COVID vaccination history.

What kind of documentation do you need?

Travelers must provide the airline with either a negative COVID-19 virus test result taken within two days of boarding the flight or proof of recovery from the virus. Documentation of his negative COVID-19 test results is in either paper or digital format. A person who tested positive for her COVID-19 more than 10 days before her flight may submit documentation proving recovery from the virus in lieu of a negative COVID-19 virus test. .

Additionally, COVID vaccination requirements continue to apply to non-U.S. citizens and non-U.S. immigrants traveling to the United States.

When are requirements active?

This COVID test result or COVID recovery document is required for travelers from 12:01 AM ET on January 5, 2023. CDC offers a travel assessment tool to help the traveler determine her COVID-related travel requirements.

What is the Traveler-Based Genome Surveillance Program (TGS)?

The Traveler-Based Genomic Surveillance Program (TGS) is a voluntary program at major U.S. international airports that allows international passengers arriving on select flights to provide anonymous nasal swabs to help prevent new COVID-19 infections. It can support early detection of 19 variants. TGS operates from his seven US airports (Atlanta, Newark, New York-JFK, Los Angeles, San Francisco, Seattle, Washington, DC-Dulles), with approximately 500 weekly flights from 30 countries. TGS has successfully detected Omnicom subvariants BA.2, BA.3 and other his COVID variants in early stages. Participation is voluntary for arriving international passengers.

Do I need to quarantine upon arrival in the US?

At this time, there are no quarantine requirements upon arrival in the United States. All travelers are encouraged to wear a mask and self-monitor for COVID symptoms while traveling. We also recommend that he take a COVID test within three days of his arrival in the United States.

The content of this article is intended to provide a general guide on the subject. You should seek professional advice for your particular situation.

Popular article: Immigrants from all over the world

Important considerations for immigrants on furlough
Buchanan Ingersoll & Rooney PC
Amid fears of a recession and rising inflation, the tech industry recently announced a number of layoffs that have negatively impacted H-1B and L-1 visa holders…

Investor visa – subject to significant changes
Buchanan Ingersoll & Rooney PC
On December 15, 2022, Congress passed the James M. Inhofe National Defense Authorization Act for fiscal year 2023. This applies, among other things, to foreigners who acquire citizenship …

About the author


Leave a Comment